• Understanding Insufficient GLP-1 Activity in T2D

  • Jan 3 2022
  • Duración: 9 m
  • Podcast

Understanding Insufficient GLP-1 Activity in T2D Por arte de portada

Understanding Insufficient GLP-1 Activity in T2D

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • What is the impact of insufficient GLP-1 activity in type 2 diabetes (T2D)? Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the role of GLP-1 in glucose regulation, consider the impact of insufficient GLP-1 activity on pancreatic beta cells in patients with T2D, and discuss possibilities to overcome insufficient GLP-1 activity in patients with T2D.

    This podcast is sponsored by Novo Nordisk and is intended for clinicians.

    Faculty Presenters:

    John E. Anderson, MD
    Internal Medicine and Diabetes
    The Frist Clinic
    Nashville, Tennessee

    Javier Morales, MD, FACP, FACE
    Internal Medicine, Diabetes, and Primary Care
    Associate Clinical Professor
    Hofstra/Northwell School of Medicine at the Donald and Barbara Zucker School of Medicine
    Long Island, New York

    Richard E. Pratley, MD
    Internal Medicine and Diabetes
    AdventHealth Diabetes Institute
    Orlando, Florida
    Más Menos
activate_primeday_promo_in_buybox_DT
Más Menos

Lo que los oyentes dicen sobre Understanding Insufficient GLP-1 Activity in T2D

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles